2014 annual financial data
Summit Therapeutics 2014 Operating margin
Summit Therapeutics 2014 operating margin with verified reported values.
Direct answer
Operating margin was -647.93%.
Operating income was -12,233,000 GBP and net income was -11,384,000 GBP.
Operating cash flow was -16,587,313 GBP.
Get free Summit Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 1,888,000 GBP
- Operating income
- -12,233,000 GBP
- Net income
- -11,384,000 GBP
- Operating cash flow
- -16,587,313 GBP